Harada K - Search Results

1

Effect of KRN2391 on canine ventricular arrhythmia models.

Takeuchi A, Harada K, Miwa A, Jinno Y, Kaneta S, Yokoyama T, Ogawa N. Takeuchi A, et al. Among authors: harada k. Gen Pharmacol. 1994 Jan;25(1):53-60. doi: 10.1016/0306-3623(94)90009-4. Gen Pharmacol. 1994. PMID: 8043150

2

Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs.

Ogawa N, Jinno Y, Kaneta S, Harada K, Fukata Y, Fukushima H. Ogawa N, et al. Among authors: harada k. J Cardiovasc Pharmacol. 1993 Jun;21(6):874-82. doi: 10.1097/00005344-199306000-00005. J Cardiovasc Pharmacol. 1993. PMID: 7687711

3

Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.

Harada K, Miwa A, Kaneta S, Izawa T, Fukushima H, Ogawa N. Harada K, et al. Br J Pharmacol. 1993 Jul;109(3):679-84. doi: 10.1111/j.1476-5381.1993.tb13627.x. Br J Pharmacol. 1993. PMID: 7689399 Free PMC article.

4

Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig.

Harada K, Miwa A, Yokoyama T, Izawa T, Ogawa N, Jinno Y. Harada K, et al. Gen Pharmacol. 1994 Sep;25(5):935-9. doi: 10.1016/0306-3623(94)90099-x. Gen Pharmacol. 1994. PMID: 7835640

5

Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.

Kasai H, Fukata Y, Harada K, Fukushima H, Ogawa N. Kasai H, et al. Among authors: harada k. J Pharm Pharmacol. 1993 Mar;45(3):222-4. doi: 10.1111/j.2042-7158.1993.tb05538.x. J Pharm Pharmacol. 1993. PMID: 8097782

6

Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.

Harada K, Fukata Y, Miwa A, Kaneta S, Fukushima H, Ogawa N. Harada K, et al. Jpn J Pharmacol. 1993 Sep;63(1):35-9. doi: 10.1254/jjp.63.35. Jpn J Pharmacol. 1993. PMID: 8271529 Free article.

7

Effects of K+ channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart.

Ohta H, Nakazawa H, Jinno Y, Harada K, Ogawa N, Miwa A, Nishikori K. Ohta H, et al. Among authors: harada k. Eur J Pharmacol. 1993 Feb 16;231(3):323-30. doi: 10.1016/0014-2999(93)90106-r. Eur J Pharmacol. 1993. PMID: 8449225

8

Tolerance to the increase in coronary blood flow induced by KRN2391.

Kaneta S, Jinno Y, Harada K, Fukushima H, Ogawa N. Kaneta S, et al. Among authors: harada k. Arch Int Pharmacodyn Ther. 1992 Jul-Aug;318:21-35. Arch Int Pharmacodyn Ther. 1992. PMID: 1463369

9

Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart.

Ohta H, Jinno Y, Harada K, Ogawa N, Fukushima H, Nishikori K. Ohta H, et al. Among authors: harada k. Eur J Pharmacol. 1991 Nov 5;204(2):171-7. doi: 10.1016/0014-2999(91)90702-r. Eur J Pharmacol. 1991. PMID: 1839621

10

Effects of pegylated recombinant human megakaryocyte growth and development factor on 5-fluorouracil-induced thrombocytopenia in balloon-injured rats.

Harada K, Tazunoki Y, Ide Y, Takeuchi A, Kawahara J, Suzuki T. Harada K, et al. J Pharm Pharmacol. 2000 Mar;52(3):321-5. doi: 10.1211/0022357001773869. J Pharm Pharmacol. 2000. PMID: 10757421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,998 results

Search Page

Filters